Establishment Labs Plans Q3 2024 Financial Results Announcement
Establishment Labs Holdings Inc. (NASDAQ: ESTA), renowned for its commitment to advancing women’s health and wellness, is gearing up to announce its financial results for the third quarter, specifically for the period ending September 30, 2024. This announcement will take place following the market's close on a Thursday in early November. In addition to the results announcement, Establishment Labs will conduct a conference call at 4:30 pm ET for investors and stakeholders.
Details of the Financial Results Announcement
Individuals interested in participating in the conference call can easily join by dialing the provided numbers: (877) 407-8037 for U.S. and Canadian residents or (201) 689-8037 for international participants. The conference ID to access the call will be 13749629. This session will not just cover the financial results; it’s an opportunity for management to discuss future strategies and insights. Additionally, the conference will be available to stream live, or as an archived session, through the Investor Relations section of the Establishment Labs website.
About Establishment Labs
Establishment Labs isn’t just another medical tech company; it’s a pioneer committed to enhancing the quality of women’s health care. They utilize innovative science and engineering to provide state-of-the-art solutions, particularly in breast aesthetics and reconstructive surgery. Their portfolio includes a variety of Femtech solutions tailored for breast health, which are revolutionizing traditional practices.
Innovative Product Offerings
One of the standout offerings from Establishment Labs is the Motiva product line, which has established a reputation for excellence since its launch in 2010. Over nearly four million Motiva devices have been delivered to surgeons worldwide, influencing positive outcomes for patients in over 85 countries. Notably, the Motiva Flora tissue expander stands out due to its unique features, including an integrated port that utilizes cutting-edge radio-frequency technology, making it MRI conditional.
Commitment to Research and Quality
Establishment Labs takes pride in its extensive commitment to research and innovation. With over 200 patent applications filed and more than 100 studies published in peer-reviewed journals, the company is at the forefront of medical technology advancements. This dedication to quality has led to their manufacturing processes being compliant with rigorous standards, ensuring that their products meet high safety benchmarks.
Investing in Women's Health
Establishment Labs is not only shaping the present landscape of women's health technologies but is also paving the way for future advancements. The launch of Mia Femtech™, a pioneering minimally invasive solution designed for achieving breast harmony, exemplifies their innovative spirit. Such products represent a significant leap forward, allowing for safer and more effective options for women undergoing breast surgery.
Future Prospects and Market Impact
The upcoming financial results will provide a critical glimpse into Establishment Labs' performance and strategic direction. With ongoing innovations and a strong foundation in research and development, the company is well-positioned to continue leading the market in women's health technologies. Investors and stakeholders will be keenly awaiting insights from the upcoming announcement as it is expected to influence market perceptions and the company's future trajectory.
Frequently Asked Questions
When is the financial results announcement for Q3 2024?
The announcement will occur after market close on a Thursday in early November 2024.
How can I participate in the conference call?
You can join the conference call by dialing (877) 407-8037 for U.S. participants or (201) 689-8037 for international participants.
What products does Establishment Labs offer?
Establishment Labs offers a range of Femtech solutions, including the Motiva devices and the Mia Femtech™ product line.
How does Establishment Labs ensure product safety?
The company complies with regulatory standards such as ISO13485:2016 and FDA regulations, ensuring high safety and quality benchmarks for all their products.
What is the focus of Establishment Labs?
Establishment Labs is dedicated to improving women’s health and wellness through science-driven innovations in breast health and aesthetics.